Revolutionizing Gene Detection: Tianlong's SMN1 Gene Detection Kit
Release Date 2023-08-11

As the leading provider of innovative genetic solutions, Tianlong is proud to introduce our groundbreaking SMN1 Gene Detection Kit. Designed specifically for accurate and comprehensive spinal muscular atrophy (SMA) genetic testing, this kit offers unparalleled benefits and advantages that revolutionize the field of gene detection.

P124H-Human Survival Motor Neuron 1 (SMN1) Gene Detection Kit 1--V3-20230520.png

Accurate and comprehensive spinal muscular atrophy gene testing

At the heart of our SMN1 Gene Detection Kit lies its enhanced gene detection capability. We have developed a cutting-edge technology that accurately detects the copy number of SMN1 at the 7th exon and/or the 8th Exton in human genomic DNA. This level of precision allows healthcare professionals to identify patients with SMA more effectively and make informed treatment decisions.

What sets our kit apart is its ability to differentiate between 0, 1, and >2 copies of SMN1. By providing comprehensive testing, we empower medical practitioners with precise information about the patient's genetic makeup, enabling them to offer personalized care and tailored treatment plans.

Streamlined workflow and accessibility

We understand the importance of efficiency in the healthcare industry. That's why we have optimized the workflow of our SMN1 Gene Detection Kit to enable a seamless DNA-to-data process in just 2-3 hours with minimal hands-on time. This streamlined workflow saves both time and resources, allowing healthcare professionals to focus on what matters most - patient care.

Another key advantage of our kit is its low sample concentration requirement of 10ng/uL. This accessibility feature ensures that our kit can be used in various testing scenarios, even when the sample size is limited. Whether it's a small research laboratory or a large-scale clinical setting, our kit accommodates diverse needs without compromising accuracy.

Compliance and accessibility

Tianlong is committed to delivering products that meet global standards. Our SMN1 Gene Detection Kit proudly carries the CE mark, indicating compliance with European regulations. Additionally, we have obtained the NMPA mark, signifying our commitment to accessibility and approval for use in multiple countries. With this recognition, our kit offers peace of mind to healthcare professionals worldwide, ensuring they can rely on our technology with confidence.


In conclusion, Tianlong's SMN1 Gene Detection Kit is transforming the way genetic testing is approached. With its enhanced gene detection capability, streamlined workflow, and global compliance, our kit empowers medical professionals to make accurate diagnoses and provide personalized care to patients with spinal muscular atrophy. Join us in revolutionizing gene detection and shaping a brighter future for precision medicine.